STERLING S.P.A.’s Post

Thoughts on this? >> J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #productmarketing #biotech

Thoughts on this? >> J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharmaceutical #pharma #healthcare

𝐍𝐞𝐰 𝐃𝐫𝐮𝐠 𝐌𝐨𝐝𝐚𝐥𝐢𝐭𝐢𝐞𝐬 𝟐𝟎𝟐𝟓: 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 💊 The pharmaceutical landscape is undergoing a transformative shift as new drug modalities emerge to address previously unmet medical needs. In 2025, these cutting-edge approaches are redefining drug discovery and development, promising breakthroughs in treatment paradigms. At Pragma Market Research and Business Consulting, we delve into the most significant trends shaping this dynamic sector. 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞: https://lnkd.in/gfGvMEb7 #drugdiscovery #medicine #pharma #pharmaceutical

Thoughts on this? >> Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharma #pharmaceutical #healthcare

We’re excited to share key insights from our recent Drug-Drug Interaction (DDI) study involving combined oral contraceptive (COC). For in-depth insights and collaboration opportunities 📧 BD@novumprs.com. #DrugInteraction #COC #DDI #NovumPRS #ClinicalResearch #ClinicalTrials #Phase1 #Phase1Trials #EarlyPhase #ClinicalResearchExcellence #LasVegas #Phase1Unit #MedicalResearch #ClinicalDevelopment #GlobalCRO #FullserviceCRO #DrugDevelopment #Pharmaceuticals #Pharmaceutical #Research #Biopharma #InnovatewithNovum #LambdaTherapeuticResearch #RegulatoryCompliance Lambda Therapeutic Research Dr. Mrinal Kammili Cathy Lopez Netal Desai, MD, MBA David Bell-Pruitt Niraj Shethji

Honored to share that my review article, "A Comprehensive Overview of Microspheres as a Novel Drug Delivery System," is published in the International Journal of Pharmaceutical Sciences. A big thank you to my mentors and peers for their support. The study focuses on the potential of microspheres as a novel drug delivery system, highlighting their versatility in encapsulating various drugs and providing controlled and targeted release to enhance drug efficacy and minimize side effects. Microspheres enable sustained drug release, which reduces dosing frequency and improves patient compliance, making them particularly useful for chronic conditions and targeted therapies. Despite challenges like complex manufacturing, ongoing advancements are addressing these issues, solidifying the role of microspheres in modern medicine and therapeutic innovation. #AcademicLife #ResearchPublication #PharmaceuticalInnovation

Analyzing the impact of biosimilars on #biologic #drug #manufacturing technologies Biosimilars have been transforming the #biopharmaceutical landscape by offering cost-effective alternatives to biologic drugs. As patents for these biologics expire, the market for biosimilars is expanding rapidly, with significant implications for manufacturing technologies. This article delves into the impact of biosimilars on biologic drug manufacturing technologies, highlighting the challenges, opportunities, and future directions in this field. https://lnkd.in/em-E8REg

Thoughts on this? >> Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #healthcare #biotech

The pharmaceutical industry is racing to redefine weight loss treatments, with a few leading companies dominating the landscape while others pursue advancements in efficacy, convenience, and fewer side effects. Upcoming trial results in the next six months could potentially reshape the market and drive a new phase of innovation in GLP-1 agonists. 💡 Read the article: https://lnkd.in/geTndYSc #GLP1 #Patients #Healthcare #Innovation #Pharmaceutical #Pharma #WeightLoss #ObesityTrials

CDMOs are pivotal in transforming India's healthcare landscape by accelerating drug development, enhancing manufacturing capabilities, and supporting biopharmaceutical advancements. Their role ensures faster access to innovative treatments and high-quality medicines. Learn more about how CDMOs are shaping the future of healthcare. https://lnkd.in/dq9T-BB8 #HealthcareInnovation #Pharmaceuticals #Biotechnology #DrugDevelopment #IndiaHealthcare Rishabh Bhawsar